Etiology, diagnostics and therapy of hyponatremias;A hyponatraemiás állapotok etiológiája, diagnosztikája és terápiája

Orvosi Hetilap

Volumn 149, Issue 29, 2008, Pages 1347-1354

  Laczi, Ferenc ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b NONE   (Hungary)

Author keywords

Hyponatremia; Vasopressin

Indexed keywords

CONIVAPTAN; DEMECLOCYCLINE; FUROSEMIDE; GLUCOSE DERIVATIVE; LIPID; LITHIUM; LIXIVAPTAN; PROTEIN DERIVATIVE; SATAVAPTAN; SODIUM; SODIUM CHLORIDE; TOLVAPTAN; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR ANTAGONIST;

ARTICLE; CLINICAL ASSESSMENT; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DRUG MECHANISM; EMERGENCY CARE; EXTRACELLULAR FLUID; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; HYPERVOLEMIA; HYPONATREMIA; HYPOVOLEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY CONCENTRATING CAPACITY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PLASMA OSMOLALITY; REFERENCE VALUE; SALT LOSING NEPHRITIS; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; SYMPTOMATOLOGY; URINE OSMOLALITY; VASOPRESSIN RELEASE; WATER DEPRIVATION; WATER INTOXICATION;

EID: 49449107218     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2008.28409     Document Type: Article

References (44)

1. Verbalis, J. G.: Inappropriate antidiuresis and other hypoosmolar states. In: Principles and practice of endocrinology and metabolism. Szerk.: Becker, K. L. Lippincott Co., Philadelphia, 2001, 293-305.
2. Miller, M., Morley, J. E., Rubenstein, L. Z.: Hyponatraemia in a nursing home population. J. Am. Geriatr. Soc., 1995, 43, 1410-1413.
3. Reynolds, R. M., Seckl, J. R.: Hyponatraemia for the clinical endocrinologist. Clin. Endocrinol., 2005, 63, 366-374.
4. Adrogué, H. J., Madias, N. E.: Hyponatraemia. N. Engl. J. Med., 2000, 342, 1581-1589.
5. Arieff A. I., Llach, F., Massry, S. G.: Neurological manifestations and morbidity of hyponatraemia: correlation with brain water and electrolytes. Medicine, 1976, 55, 121-129.
6. Lien, Y-H. H., Shapiro, J. I.: Hyponatraemia: clinical diagnosis and management. Am. J. Med., 2007, 120, 653-658.
7. Hussain, S. M., Sureshkumar, K. K., Marcus, R. J.: Recent advances in the treatment of hyponatraemia. Expert Opin. Pharmacother., 2007, 8, 2729-2741.
8. Moore, K., Thompson, C., Trainer, P.: Disorders of water balance. Clin. Med., 2003, 3, 28-33.
9. Bert, T., Anderson, R. J., McDonald, K. M. és mtsa: Clinical disorders of water metabolism. Kidney Int., 1976, 10, 117-132.
10. Rai, A., Whaley-Connel, A., McFarlane, S. és mtsa: Hyponatraemia, arginin vasopressin dysregulation, and vasopressin receptor antagonism. Am. J. Nephrol., 2006, 26, 579-589.
11. Laczi, F., Janáky, T., Iványi, T. és mtsai: Osmoregulation of arginine-8-vasopressin secretion in primary hypothyroidism and in Addison's disease. Acta Endocrinol. (Copenh.), 1987, 114, 389-395.
12. Schrier, R. W., Goldberg, J. P.: The physiology of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid and edematous disorders. Yale J. Biol. Med., 1980, 53, 525-541.
13. Goldsmith, S. R., Cowleyaw, F. G. S., Levine, T. B. és mtsa: Increased plasma arginine vasopressin level in patients with congestive heart failure. J. Am. Coll. Cardiol., 1983, 1, 1388-1390.
14. Bichet, D., Szatalowicz, V., Chaimovitz, C. és mtsa: Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann. Intern. Med., 1982, 96, 413-417.
15. Ishikawa, S., Schrier, R. W.: Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion. Clin. Endocrinol., 2003, 58, 1-17.
16. Saito, T., Ishikawa, S., Abe, K. és mtsai: Acute aquaresis by the nonpeptide arginin vasopressin (AVP) antagonist OPC-31260 improves hyponatraemia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J. Clin. Endocrinol. Metab., 1997, 82, 1054-1057.
17. Laczi, F.: Neurohypophysis. Vasopressin és oxytocin. In: A klinikai endokrinológia és anyagcsere-betegségek kézikönyve. Szerk.: Leövey, A. Medicina Könyvkiadó Rt., Budapest, 2001, 207-215.
18. Schwartz, W. B., Bennett, S., Curelop, S. és mtsai: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am. J. Med., 1957, 23, 529-542.
19. Brodmann, S., Klaas, E. G., Cathomas, R. és mtsai: Severe hyponatremia in a patient with mantle cell lymphoma treated with bortezomib: a case report and review of the literature. Onkologie, 2007, 30, 651-654.
20. Dóczi T., Tarjányi J., Huszka E. és mtsai: Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) after head injury. Neurosurgery, 1982, 10, 685-688.
21. Laczi F., Szasz A., Vecsernyes M. és mtsa.: Neurohypophysial hormone secretion in hyperprolactinaemic women. Neuropeptides, 1998, 32, 435-437.
22. Dhawan, A., Warang, A., Singhi, S.: Hyponatraemia and the inappropriate ADH syndrome in pneumonia. Ann. Trop. Paediatr., 1992, 12, 455-462.
23. Valkusz Zs., Laczi F., László F. A.: Development of the Schwartz-Bartter syndrome after the administration of chlorpropamide and 1-deamino-8-D-arginine vasopressin. Endokrinologie, 1982, 79, 345-348.
24. Jojárt I., Laczi F., László F. A. és mtsai: Hyponatraemia and increased secretion of vasopressin induced by vincristine administration in rat. Exp. Clin. Endocrinol., 1987, 90, 213-220.
25. Feldman, B. J., Rosenthal, S. M., Vargas, G. A. és mtsai: Nephrogenic syndrome of inappropriate antidiuresis. N. Engl. J. Med., 2005, 352, 1884-1890.
26. Hillier, T. A., Abbott, R. D., Barrett, E. J.: Hyponatraemia: evaluating the correction factor for hyperglycemia. Am. J. Med., 1999, 106, 399-403.
27. McGirt, M. J., Blessing, R., Nimjee, S. M. és mtsai: Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery, 2004, 54, 1369-1373.
28. Harrigan, M. R.: Cerebral salt wasting syndrome. Crit. Care Clin., 2001, 17, 125-138.
29. Cardoso, A. P. D., Dragosavac, D., Araújo, S. és mtsai: Syndromes related to sodium and arginin vasopressin alterations in post-operative neurosurgery. Arq. Neuro-Psiquiatr., 2007, 65(3B), 745-751.
30. Clung, H. M., Kluge, R., Schrier, R. W. és mtsai: Clinical assessment of extracellular fluid volume in hyponatremia. Am. J. Med., 1987, 83, 905-908.
31. Douglas I.: Hyponatremia: why it matters, how it presents, how we can manage it. Clev. Clin. J. Med., 2006, 73, S4-S12.
32. Sterns, R. H.: Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases. Ann. Intern. Med., 1987, 107, 656-664.
33. Lee, W. H., Packer, M.: Prognostic inportance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation, 1986, 73, 257-267.
34. Kumar, S., Berl, T.: Sodium. Lancet, 1998, 352, 220-228.
35. Beck, L. H.: Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N. Engl. J. Med., 1979, 301, 528-530.
36. Ball, S. G., Barter, T., Baylis, P. H.: Tests of posterior pituitary function. J. Endocrinol. Invest., 2003, 26 (Suppl. to no. 7), 15-24.
37. Smith, D. M., McKenna, K., Thompson, C. J.: Hyponatraemia. Review. Clin. Endocrinol., 2000, 52, 667-678.
38. Sterns, R. H., Silver, S. M.: Cerebral salt wasting versus SIADH: what difference? J. Am. Soc. Nephrol., 2008, 19, 194-196.
39. Oelkers, W.: Hyponatraemia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N. Engl. J. Med., 1989, 321, 492-496.
40. Reeves, W. B., Andreoli, T. E.: The posterior pituitary and water metabolism. In: Williams Textbook of Endocrinology. Szerk.: Wilson, J. D., Foster, D. W. N. B. Saunders Co., Philadelphia, 1992, 311-356.
41. Arieff A. I.: Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N. Engl. J. Med., 1986, 314, 1529-1535.
42. Martin, R. J.: Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J. Neurol. Neurosurg. Psychiatry, 2004, 75 (Suppl 3), iii22-iii28.
43. Forrest, J. N., Cox, M., Hong, C. és mtsai: Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N. Engl. J. Med., 1978, 298, 173-177.
44. Decaux, G.: Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea or furosemide. Am. J. Med., 2001, 110, 582-584.